This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (16)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Pathology & Laboratory Medicine  • Gastroenterology  • Gastrointestinal Diseases  • Alert me on articles by topic  Social Bookmarking   What's this?

Mark Feldman, MD; Byron Cryer, MD; Edward Lee, MD; Walter L. Peterson, MD

JAMA. 1998;280:363-365.

Context.— The role of serologic testing to confirm cure of Helicobacter pylori infection after antimicrobial therapy is not completely defined.

Objective.— To determine the utility of serologic testing in confirming cure of H pylori infection more than 1 year after therapy.

Design.— A prospective, before-after interventional trial.

Setting.— An outpatient clinical research laboratory in an academic, urban Veterans Affairs medical center.

Participants.— Twenty-three otherwise healthy men and women with active H pylori infection demonstrated by gastric biopsy and with positive H pylori serologic findings.

Intervention.— A 14-day course of bismuth, tetracycline, and metronidazole.

Main Outcome Measures.— Determination of IgG serum antibodies to H pylori at baseline, 1 month, 3 months, and approximately 18 months after completion of therapy compared with serial gastric mucosal biopsy specimens with stains for H pylori and for histologic examination as the criterion standard.

Results.— Fifteen (65%) of 23 subjects were cured of their H pylori infection as assessed by gastric biopsy, with elimination of gastritis; median antibody levels declined from 92.5 U/mL at baseline to undetectable levels at 18 months. The other 8 subjects (35%) were not cured and had persistent gastritis at 18 months; median antibody levels declined from 130.6 U/mL at baseline to 89.7 U/mL at 18 months. Sensitivity and specificity of seroconversion (from a positive to negative test result) in detecting cure of H pylori infection were 60% and 100%, respectively.

Conclusion.— Undetectable antibody levels beyond the first year of therapy accurately confirm cure of H pylori infection in initially seropositive healthy subjects, with reasonable sensitivity.

From the Departments of Internal Medicine (Drs Feldman, Cryer, and Peterson) and Pathology (Dr Lee), University of Texas Health Science Center at Dallas, and the Medical (Drs Feldman, Cryer, and Peterson) and Laboratory (Dr Lee) Services of the Department of Veterans Affairs Medical Center, Dallas, Tex.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Associations between Three Types of Maternal Bacterial Infection and Risk of Leukemia in the Offspring
Lehtinen et al.
Am J Epidemiol 2005;162:662-667.
ABSTRACT | FULL TEXT  

Helicobacter pylori-Related Disease: Guidelines for Testing and Treatment
Peterson et al.
Arch Intern Med 2000;160:1285-1291.
ABSTRACT | FULL TEXT  

Seroconversion a New Way to Determine H. pylori Cure
JWatch Infect. Diseases 1998;1998:19-19.
FULL TEXT